Acta Med. 2022, 65: 139-143
https://doi.org/10.14712/18059694.2023.4
Performance Characteristics and Utility of the Standard Q COVID-19 Antigen Test for Emergency Admissions to Healthcare Facilities
Amela Dedeić-Ljubović
, El Jesah Ðulić, Erna Husić, Jasmina Halković, Džemilja Gačanović, Irma Salimović-Bešić
, El Jesah Ðulić, Erna Husić, Jasmina Halković, Džemilja Gačanović, Irma Salimović-Bešić
Clinical Center of the University of Sarajevo, Unit of Clinical Microbiology; Sarajevo, Bosnia and Herzegovina
Received September 7, 2022
Accepted December 23, 2022
References
1. G, Croxatto A, Kampouri E, et al. Implementing SARS-CoV-2 Rapid Testing in the Emergency Ward of a Swiss University Hospital: The INCREASE Study. Microorganisms 2021; 9(4): 798.
<https://doi.org/10.3390/microorganisms9040798>
<PubMed>
2. Y, Yao L, Li J, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol 2020; 92(7): 903–8.
<https://doi.org/10.1002/jmv.25786>
<PubMed>
3. MN, Whitney ON, Chong S, Maurer A, Darzacq X, Tjian R. Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection. RNA 2020; 26(7): 771–83.
<https://doi.org/10.1261/rna.076232.120>
<PubMed>
4. NJ, Poole S, Naidu VV, et al. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective,interventional, non-randomised, controlled study. Lancet Respir Med 2020; 8(12): 1192–200.
<https://doi.org/10.1016/S2213-2600(20)30454-9>
<PubMed>
5. B, Wen K, Zhang J, Chen J, Han C, Chen Y, et al. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection. ClinMicrobiol Infect 2021; 27(2): 289.E1–289.E4.
<https://doi.org/10.1016/j.cmi.2020.09.057>
<PubMed>
6. Diagnostic testing for SARS-CoV-2. Interim guidance. 11 September 2020. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2, accessed 18 November 2020).
7. World Health Organization. (2021). Antigen-detection in the diagnosis of SARS-CoV-2 infection: interim guidance, 6 October 2021. World Health Organization. https://apps.who.int/iris/handle/10665/345948. IGO WHO reference number: WHO/2019-nCoV /Antigen_Detection/2021.1.
8. Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: A preliminary report. J Infect 2021; 82: e14–e16.
9. J, Deeks JJ, Berhane S, Taylor M, Adriano A, Davenport C, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 2021; 3(3): CD013705.
10. CDC. Coronavirus disease 2019 (COVID-19): interim guidance for antigen testing for SARS-CoV-2. CDC; 2021 Revised April 13, 2021.
11. RW, Olliaro PL, Boeras DI, Fongwen N. Scaling up COVID-19 rapid antigen tests: promises and challenges. Lancet Infect Dis 2021; 21(9): 290–5.
<https://doi.org/10.1016/S1473-3099(21)00048-7>
<PubMed>
12. J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et.al. Rapid, point-of-care antigen and molecular-based tests for diagnosisof SARS-CoV-2 infection. Cochrane Database Syst Rev 2020; 8: CD013705.
